Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.
Reviews
There are no reviews yet.
Be the first to review “DIAMPA M XR 25MG /1000MG TAB” Cancel reply
Reviews
There are no reviews yet.